DCM
ALXO icon

Driehaus Capital Management’s ALX Oncology ALXO Stock Holding History

Driehaus Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
5,734,620
+4,311,738
+303% +$8.21M 0.08% 259
2025
Q4 		$1.61M Buy
1,422,882
+627,105
+79% +$950K 0.01% 339
2025
Q3 		$1.46M Buy
+795,777
New +$689K 0.01% 361

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Driehaus Capital Management's ALXO Position: Q1 2026 in Review

Driehaus Capital Management increased its ALX Oncology (ALXO) stake by 303% in Q1 2026, buying an estimated $8.21M and bringing the position to 5,734,620 shares worth $11.5M. The position accounts for 0.08% of the portfolio, ranked #259.

Driehaus Capital Management first reported a position in ALXO in Q3 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Driehaus Capital Management held 5,734,620 shares of ALX Oncology worth $11.5M as of Q1 2026.
  • Driehaus Capital Management bought 4,311,738 ALX Oncology shares in Q1 2026, an estimated $8.21M.
  • ALX Oncology made up 0.08% of Driehaus Capital Management's portfolio in Q1 2026, its #259 holding.
  • Driehaus Capital Management first reported a position in ALX Oncology in Q3 2025 and has held it in 3 quarters since.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.